did the fda ban compounded semaglutide π¨ Moves to Permanently Shut Down GLP-1s FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA announces ban for compounded
Description
Andueza, Naroa, et al
513,522 In a mouse model induced with NASH-related HCC, treatment with liraglutide (a type of GLP-1RA) was shown to prevent the progression of hepatocellular carcinoma
That's not a reason to automatically say no
It may also request more data, labeling changes, or manufacturing clarifications before making a decision
Never disregard professional medical advice or delay seeking care because of something you have read here
